Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,268
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,852
Class I recallsReasonable probability of serious health consequences
24,397
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,085 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2

Showing 1,121–1,140 of 21,230 recalls

FDA Recall United States OngoingHistorical recordClass II

Admiralty Island Fisheries Inc dba AquaStar (USA) Corp.

Product
AquaStar 16/20 Frozen Raw EZ-Peel White Shrimp, net wt. 5 lb…
Reason
Shrimp may be contaminated with Cesium-137 (Cs-137).
Published
November 12, 2025
Distribution
Nationwide

View recall →

FDA Recall United States OngoingHistorical recordClass II

Admiralty Island Fisheries Inc dba AquaStar (USA) Corp.

Product
Waterfront Bistro Frozen Raw EZ-Peel White Shrimp 21/25, net…
Reason
Shrimp may be contaminated with Cesium-137 (Cs-137).
Published
November 12, 2025
Distribution
Nationwide

View recall →

FDA Recall United States OngoingHistorical recordClass II

Admiralty Island Fisheries Inc dba AquaStar (USA) Corp.

Product
Best Yet Frozen Raw EZ-Peel White Shrimp 16/20 (net wt. 1 l…
Reason
Shrimp may be contaminated with Cesium-137 (Cs-137).
Published
November 12, 2025
Distribution
Nationwide

View recall →

FDA Recall United States OngoingHistorical recordClass II

Admiralty Island Fisheries Inc dba AquaStar (USA) Corp.

Product
AquaStar Raw Peeled Tail-on Shrimp Skewers, net wt. 1.25lbs.…
Reason
Shrimp may be contaminated with Cesium-137 (Cs-137).
Published
November 12, 2025
Distribution
Nationwide

View recall →

FDA Recall United States OngoingHistorical recordClass II

Admiralty Island Fisheries Inc dba AquaStar (USA) Corp.

Product
Kroger Mercado Cooked Medium Peeled Tail-Off Shrimp, net wt.…
Reason
Shrimp may be contaminated with Cesium-137 (Cs-137).
Published
November 12, 2025
Distribution
Nationwide

View recall →

FDA Recall United States OngoingHistorical recordClass II

Admiralty Island Fisheries Inc dba AquaStar (USA) Corp.

Product
Kroger Raw Colossal EZ Peel Shrimp, net wt. 2lbs., UPC 20011…
Reason
Shrimp may be contaminated with Cesium-137 (Cs-137).
Published
November 12, 2025
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: April 29, 2026Historical recordClass I

Teasdale Foods, Inc.

Product
Casa Mamita Soft Taco Dinner Kit, Net Wt 13.4 OZ (379g), UPC…
Reason
Undeclared allergen - milk
Published
November 12, 2025
Distribution
Multiple states

View recall →

FDA Recall United States TerminatedTerminated: April 29, 2026Historical recordClass I

Teasdale Foods, Inc.

Product
Giant/Martin's Crunchy Taco Dinner Kit, Net Wt 9.4 OZ (266g)…
Reason
Undeclared allergen - milk
Published
November 12, 2025
Distribution
Multiple states

View recall →

FDA Recall United States TerminatedTerminated: April 21, 2026Historical recordClass I

New York Mutual Trading, Inc.

Product
Frozen Crab Paste; 3.5 OZ (100g); Imported by Mutual Tading…
Reason
Undeclared allergen ingredients (fish, soy, and wheat)
Published
November 12, 2025
Distribution
Products were labeled "not for retail sa…

View recall →

FDA Recall OngoingHistorical recordClass II

Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-048-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx only, Manufactured by: USV Private Limited, Daman, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816.

by Heritage Pharmaceuticals Inc

Reason
CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-052-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-051-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-050-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-049-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-047-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lisdexamfetamine Dimesylate Capsules, 10 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-046-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC 0990-7984-37

by Otsuka ICU Medical LLC

Reason
Lack of Assurance of Sterility: Potential for flexible container leaks.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass III

Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91

by ENDO USA, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Published
November 5, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass III

Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-128-91

by ENDO USA, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Published
November 5, 2025
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.